PTPRC and cardiac hypertrophy: In concordance with the only 2 studies in mice found in the literature, we observed sustained macroscopic and microscopic cardiac hypertrophy (16); ICAM-1 endothelial expression, inflammation in the vascular wall (e.g., CD45-positive cell infiltration), and oxidative stress (17) that persisted after AngII withdrawal.